(2-((8S,9R,10S,11S,13S,14S,16R,17R)-9-BROMO-11,17-DIHYDROXY-10,13,16-TRIMETHYL-3-OXO-6,7,8,11,12,14,15,16-OCTAHYDROCYCLOPENTA(A)PHENANTHREN-17-YL)-2-OXOETHYL) PROPANOATE
UNII 4LG8TX93ZE
Substance Identification & Data
This profile provides standardized clinical and technical data for (2-((8s,9r,10s,11s,13s,14s,16r,17r)-9-bromo-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta(a)phenanthren-17-yl)-2-oxoethyl) Propanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4LG8TX93ZE.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H33BrO6 QYFNDGVWJDOQTC-OCUNRLNVSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2-((8s,9r,10s,11s,13s,14s,16r,17r)-9-bromo-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta(a)phenanthren-17-yl)-2-oxoethyl) Propanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.